Symbiotec Pharmalab Limited

Symbiotec Pharmalab Limited

Symbiotec Pharmalab Limited has informed the Exchange regarding 'Update on Intimation under Regulation 8(2) of the Securities and Exchange Board of India(Prohibition of Insider Trading) Regulations, 2015'. The company has framed a Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information.

Symbiotec Pharmalab Limited

Symbiotec Pharmalab Limited has informed the Exchange regarding the authorization of Key Managerial Personnel to determine materiality of events or information and make disclosures to the stock exchange.

Symbiotec Pharmalab Limited

Symbiotec Pharmalab Limited has informed the Exchange regarding 'Intimation under Regulation 8(2) of the Securities Exchange Board of India (Prohibition of Insider Trading) Regulation 2015.' and enclosed the Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information.

Symbiotec Pharmalab Limited

Symbiotec Pharmalab Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.